Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tamar Tadmor & Aaron Polliack. (2012) Elevated soluble CD 27 levels (TNF-receptor) may predict survival in diffuse large B-cell lymphoma - revisiting “the super- family “ saga.. Leukemia & Lymphoma 53:8, pages 1439-1440.
Read now
Read now
Articles from other publishers (21)
Toshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi, Miki Takahara, Kan Kishibe, Shunsuke Yasuda, Yuki Yajima, Akemi Kosaka, Takayuki Ohkuri, Kensuke Oikawa, Shohei Harabuchi, Michihisa Kono, Hidekiyo Yamaki, Risa Wakisaka, Yui Hirata-Nozaki, Kenzo Ohara, Takumi Kumai, Akihiro Katada, Tatsuya Hayashi, Yasuaki Harabuchi & Hiroya Kobayashi. (2023) Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy. Cancer Immunology, Immunotherapy 72:7, pages 2087-2098.
Crossref
Crossref
Léonie Cagnet, Déborah Neyrinck-Leglantier, Marie Tamagne, Lylia Berradhia, Mehdi Khelfa, Sabine Cleophax, France Pirenne & Benoît Vingert. (2023) CD27+ microparticle interactions and immunoregulation of CD4+ T lymphocytes. Frontiers in Immunology 14.
Crossref
Crossref
Tal Flieswasser, Astrid Van den Eynde, Jonas Van Audenaerde, Jorrit De Waele, Filip Lardon, Carsten Riether, Hans de Haard, Evelien Smits, Patrick Pauwels & Julie Jacobs. (2022) The CD70-CD27 axis in oncology: the new kids on the block. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Minh Phuong Dong, Le Thi Thanh Thuy, Dinh Viet Hoang, Hoang Hai, Truong Huu Hoang, Misako Sato-Matsubara, Vu Ngoc Hieu, Atsuko Daikoku, Ngo Vinh Hanh, Hayato Urushima, Ninh Quoc Dat, Sawako Uchida-Kobayashi, Masaru Enomoto, Naoko Ohtani, Akihiro Tamori & Norifumi Kawada. (2022) Soluble Immune Checkpoint Protein CD27 Is a Novel Prognostic Biomarker of Hepatocellular Carcinoma Development in Hepatitis C Virus–Sustained Virological Response Patients. The American Journal of Pathology 192:10, pages 1379-1396.
Crossref
Crossref
Déborah Neyrinck-Leglantier, Marie Tamagne, Sasha L’honoré, Léonie Cagnet, Sadaf Pakdaman, Alexandre Marchand, France Pirenne & BenoÎt Vingert. (2022) Autologous blood extracellular vesicles and specific CD4+ T-cell co-activation. Frontiers in Immunology 13.
Crossref
Crossref
Azhar U. Khan, Hanuman S. Dagur, Masudulla Khan, Nazia Malik, Mahboob Alam & Md Mushtaque. (2021) Therapeutic role of flavonoids and flavones in cancer prevention: Current trends and future perspectives. European Journal of Medicinal Chemistry Reports 3, pages 100010.
Crossref
Crossref
Hiroshi Nakamura, Takeshi Hara, Ryoko Mabuchi, Takuro Matsumoto, Nobuhiko Nakamura, Soranobu Ninomiya, Junichi Kitagawa, Nobuhiro Kanemura, Yusuke Kito, Tsuyoshi Takami, Tatsuhiko Miyazaki, Tamotsu Takeuchi, Masahito Shimizu & Hisashi Tsurumi. (2021) Clinical significance of oxidative stress for untreated patients with diffuse large B‑cell lymphoma. Molecular and Clinical Oncology 16:1.
Crossref
Crossref
Eivind Heggernes Ask, Astrid Tschan-Plessl, Thea Johanne Gjerdingen, Michelle Lu Sætersmoen, Hanna Julie Hoel, Merete Thune Wiiger, Johanna Olweus, Björn E. Wahlin, Ole Christian Lingjærde, Amir Horowitz, Amanda F. Cashen, Marcus Watkins, Todd A. Fehniger, Harald Holte, Arne Kolstad & Karl-Johan Malmberg. (2021) A Systemic Protein Deviation Score Linked to PD-1+ CD8+ T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell Lymphoma. Med 2:2, pages 180-195.e5.
Crossref
Crossref
Shingo Inaguma, Jerzy Lasota, Piotr Czapiewski, Renata Langfort, Janusz Rys, Joanna Szpor, Piotr Waloszczyk, Krzysztof Okoń, Wojciech Biernat, David S Schrump, Raffit Hassan, Kenji Kasai, Markku Miettinen & Hiroshi Ikeda. (2019) CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness. The Journal of Pathology 250:2, pages 205-216.
Crossref
Crossref
Tal Flieswasser, Valérie Camara-Clayette, Alina Danu, Jacques Bosq, Vincent Ribrag, Piotr Zabrocki, Luc Van Rompaey, Hans de Haard, Karen Zwaenepoel, Evelien Smits, Patrick Pauwels & Julie Jacobs. (2019) Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method. Cancers 11:10, pages 1611.
Crossref
Crossref
Jumpei Kashima, Yusuke Okuma, Yukio Hosomi & Tsunekazu Hishima. (2019) High Serum Soluble CD27 Level Correlates with Poor Performance Status and Reduced Survival in Patients with Advanced Lung Cancer. Oncology 97:6, pages 365-372.
Crossref
Crossref
Joel C. Wight, Geoffrey Chong, Andrew P. Grigg & Eliza A. Hawkes. (2018) Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Reviews 32:5, pages 400-415.
Crossref
Crossref
Bertrand Coiffier & Clémentine Sarkozy. (2016) Diffuse large B-cell lymphoma: R-CHOP failure—what to do?. Hematology 2016:1, pages 366-378.
Crossref
Crossref
Yasumasa Sugita, Chikako Ohwada, Takeharu Kawaguchi, Tomoya Muto, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Masahiro Takeuchi, Emiko Sakaida, Naomi Shimizu, Hiroaki Tanaka, Daijiro Abe, Motoharu Fukazawa, Takeaki Sugawara, Nobuyuki Aotsuka, Kaichi Nishiwaki, Katsuhiro Shono, Hiroyuki Ebinuma, Kengo Fujimura, Hideaki Bujo, Koutaro Yokote & Chiaki Nakaseko. (2016) Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis. Clinica Chimica Acta 463, pages 47-52.
Crossref
Crossref
Diana M. Castañeda, Doris M. Salgado & Carlos F. Narváez. (2016) B cells naturally induced during dengue virus infection release soluble CD27, the plasma level of which is associated with severe forms of pediatric dengue. Virology 497, pages 136-145.
Crossref
Crossref
Ruth Exner, Monika Sachet, Tobias Arnold, Mercedes Zinn‐Zinnenburg, Anna Michlmayr, Peter Dubsky, Rupert Bartsch, Guenther Steger, Michael Gnant, Michael Bergmann, Thomas Bachleitner‐Hofmann & Rudolf Oehler. (2016)
Prognostic value of
HMGB
1 in early breast cancer patients under neoadjuvant chemotherapy
. Cancer Medicine 5:9, pages 2350-2358.
Crossref
Crossref
Fatemeh Saberi Hosnijeh, Lutzen Portengen, Florentin Späth, Ingvar A. Bergdahl, Beatrice Melin, Amalia Mattiello, Giovanna Masala, Carlotta Sacerdote, Alessio Naccarati, Vittorio Krogh, Rosario Tumino, Marc Chadeau-Hyam, Paolo Vineis & Roel Vermeulen. (2016) Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: A nested case-control study and meta-analyses. International Journal of Cancer 138:10, pages 2357-2367.
Crossref
Crossref
J. Jacobs, V. Deschoolmeester, K. Zwaenepoel, C. Rolfo, K. Silence, S. Rottey, F. Lardon, E. Smits & P. Pauwels. (2015) CD70: An emerging target in cancer immunotherapy. Pharmacology & Therapeutics 155, pages 1-10.
Crossref
Crossref
Julie Jacobs, Karen Zwaenepoel, Christian Rolfo, Jolien Van den Bossche, Christophe Deben, Karen Silence, Christophe Hermans, Evelien Smits, Paul Van Schil, Filip Lardon, Vanessa Deschoolmeester & Patrick Pauwels. (2015) Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer. Oncotarget 6:15, pages 13462-13475.
Crossref
Crossref
Kengo Fujimura, Hiroyuki Ebinuma, Isamu Fukamachi, Chikako Ohwada, Takeharu Kawaguchi, Naomi Shimizu, Masahiro Takeuchi, Emiko Sakaida, Meizi Jiang, Chiaki Nakaseko & Hideaki Bujo. (2014) Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma. Clinica Chimica Acta 430, pages 48-54.
Crossref
Crossref
Sally J. Deeb, Juergen Cox, Marc Schmidt-Supprian & Matthias Mann. (2014) N-linked Glycosylation Enrichment for In-depth Cell Surface Proteomics of Diffuse Large B-cell Lymphoma Subtypes. Molecular & Cellular Proteomics 13:1, pages 240-251.
Crossref
Crossref